Clinical trials sponsored by Ausper Biopharma Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Ausper Biopharma Co., Ltd.

• A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
  NCT07600788 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 5 locations
• A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
  NCT07069569 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
• A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
  NCT07511218 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
  NCT07635186 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 34 locations
• A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
  NCT07137910 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations
• Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
  NCT07146100 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 37 locations
• Study of AHB-171 in Chronic Hepatitis B Participants
  NCT07630727 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations

Common questions

How many trials is Ausper Biopharma Co., Ltd. recruiting for?

Ausper Biopharma Co., Ltd. is the lead sponsor of 7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.